Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EPENDION AB SK 0,3333 | TW4 | Nov 19, 2024 | 7.79 | -4.65 |
Epigenomics AG | ECX | Nov 19, 2024 | 1.01 | -4.72 |
Epiroc A | 3AD1 | Nov 19, 2024 | 17.09 | +0.06 |
EPIROC AB UNSP.ADR/1 | 3ADA | Nov 19, 2024 | 16.70 | 0.00 |
Epiroc B | 3AD2 | Nov 19, 2024 | 15.40 | +0.13 |
Episurf Medical B | 16E | Nov 19, 2024 | 0.00 | -38.60 |
ePlay Digital Inc | 2NY2 | Nov 19, 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | Nov 19, 2024 | 74.00 | 0.00 |
EPR Properties | E2H | Nov 19, 2024 | 41.79 | -0.51 |
EPRCOMUNICAZIONE S.P.A. | J3P | Nov 19, 2024 | 1.14 | +1.79 |
EPTI AB AK | G7H0 | Nov 19, 2024 | 1.71 | 0.00 |
Epwin Group Plc | 2E3 | Nov 19, 2024 | 1.24 | +1.64 |
EQB INC. | V22 | Nov 19, 2024 | 73.00 | +0.69 |
EQL Pharma | 7JK | Nov 19, 2024 | 5.40 | -1.10 |
EQT | 6EQ | Nov 19, 2024 | 25.40 | +0.08 |
EQT Corporation | EQ6 | Nov 19, 2024 | 41.72 | -1.09 |
Eqtec | KEU | Nov 19, 2024 | 0.01 | +5.88 |
Equals Group Plc | 2FX | Nov 19, 2024 | 1.48 | +2.07 |
Equatorial Resources Limited | PBU | Nov 19, 2024 | 0.06 | +5.93 |
Equifax, Inc. | EFX | Nov 19, 2024 | 230.00 | -2.54 |
Equillium, Inc. | 0FY | Nov 19, 2024 | 1.16 | 0.00 |
Equinix, Inc. | EQN2 | Nov 19, 2024 | 870.00 | +2.50 |
Equinor | DNQ | Nov 19, 2024 | 22.29 | -1.65 |
Equinor ASA | DNQA | Nov 19, 2024 | 22.20 | -0.45 |
Equinox Gold Corp | 1LRC | Nov 19, 2024 | 5.15 | +0.39 |
EQUIPMAKE HLDGS LS -,0001 | U8O | Nov 19, 2024 | 0.03 | 0.00 |
Equitable Holdings Inc | AXJ | Nov 19, 2024 | 44.00 | -0.90 |
Equity Bancshares, Inc. - Class A | 44X | Nov 19, 2024 | 43.00 | -0.92 |
Equity Commonwealth | HP5A | Nov 19, 2024 | 18.80 | 0.00 |
Equity Lifestyle Properties, Inc. | MHV | Nov 19, 2024 | 66.50 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.